Quarterly report pursuant to Section 13 or 15(d)

Equity Compensation - Schedule of Stock Option Activity (Details)

v3.24.1.u1
Equity Compensation - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 12 Months Ended
Mar. 30, 2024
Dec. 30, 2023
Stock Options    
Unvested, beginning balance outstanding (in shares) 544,350  
Granted (in shares) 0  
Exercised (in shares) 0  
Vested (in shares) 0  
Forfeited (in shares) (18,796)  
Unvested, ending balance outstanding (in shares) 525,554 544,350
Vested not exercised (in shares) 175,175  
Weighted-Average Grant Date Fair Value    
Beginning balance outstanding (in dollars per share) $ 4.5  
Granted (in dollars per share) 0  
Exercised (in dollars per share) 0  
Vested (in dollars per share) 0  
Forfeited (in dollars per share) 5.3  
Ending balance outstanding (in dollars per share) 4.5 $ 4.5
Vested not exercised (in dollars per share) 4.5  
Weighted-Average Exercise Price, per share    
Beginning balance outstanding (in dollars per share) 9.4  
Granted (in dollars per share) 0  
Exercised (in dollars per share) 0  
Vested (in dollars per share) 0  
Forfeited (in dollars per share) 10.6  
Ending balance outstanding (in dollars per share) 9.4 $ 9.4
Vested not exercised (in dollars per share) $ 9.4  
Weighted Average Remaining Contractual Life (in years) 8 years 1 month 6 days 8 years 4 months 24 days
Weighted average remaining contractual life, forfeited (in years) 9 years  
Weighted average remaining contractual life, vested not exercised (in years) 8 years 1 month 6 days  
Aggregate Intrinsic Value $ 3.1 $ 2.0
Forfeited Intrinsic value 0.1  
Vested not exercised, intrinsic value $ 1.0